Mutations in EMD, encoding emerin cause skeletal muscle and heart defects in patients with X-linked EmeryDreifuss muscular dystrophy (X-EDMD) but the underlying mechanisms leading to cardiac defects are poorly understood. Here, we investigated the role of emerin in controlling cardiomyocyte proliferation and cardiac remodeling and explored its function in regulation of the Wnt/b-catenin pathway. We observed a remarkable increase of cardiomyocytes in emerin-null adult mice accompanied with decreased numbers of multinucleated cells. Depletion of emerin in mouse ES cell-derived cardiomyocytes by shRNA caused hyperactivation of Wnt/ b-catenin signaling, increased proliferation and abrogated timely cardiac differentiation. Likewise, emerinnull mice exhibited increased Wnt/b-catenin signaling, cardiac dysfunction and perturbed hypertrophic remodeling following pressure overload. Pharmacological inhibition of b-catenin normalized proliferation and differentiation of ES cell-derived cardiomyocytes while inactivation of a single allele of b-catenin efficiently rescued cardiac dysfunction in emerin-null mice. We conclude that emerin constrains b-catenin signaling in the heart providing tight control of cardiomyocyte numbers. Enhanced Wnt/b-catenin signaling seems to contribute to cardiac defects observed in X-EDMD. Hence, therapeutic inhibition of Wnt/b-catenin signaling might be beneficial for X-EDMD patients.
INTRODUCTION
The laminopathies are a group of rare life-threatening diseases caused by mutations in human genes encoding nuclear envelope (NE) or NE-associated proteins (1). Mutations in several genes including lamin A/C, emerin, MAN1, LAP2a, nesprins, ZMPSTE4 and BAF lead to phenotypically diverse disorders including Emery -Dreifuss muscular dystrophy (EDMD), limb-girdle muscular dystrophy, cardiomyopathies and Hutchinson -Gilford progeria syndrome (HGPS) (2, 3) . A prominent example is X-linked EDMD (X-EDMD), caused by mutations in the gene encoding emerin (4) . Cardiac defects observed in X-EDMD patients include dilated cardiomyopathy and conduction defects (5) . At the cellular level, emerin-mutant cells show variations in myofibre size and abnormalities in myonuclear architecture (6) . Mutations in genes encoding lamin A/C and LAP2a also lead to cardiomyopathy (7, 8) demonstrating that NE proteins play an important role in maintaining cardiac function. Increasing evidence indicates that NE proteins play critical roles in multiple cellular functions including cell cycle progression, cell signaling and maintenance of chromatin integrity. Recent work revealed that the NE plays a major role in genomic organization (9) , which might affect the balance between cell proliferation and differentiation.
The process of cellular differentiation is stringently controlled by a network of transcription factors that are regulated by effectors of several signaling pathways including Wnt/b-catenin, ERK, AKT and TGF-b. During differentiation of progenitor cells, the precise temporal and spatial activation/inactivation of these signaling pathways leads to a genome-wide redistribution of epigenetic modifications resulting in changes in chromatin structure and gene expression (10) . Animal and cellular models of laminopathies have demonstrated a role for NE proteins in regulating several signaling pathways. Inactivation of emerin, A-type lamins or LAP2a in mice or mutations of EMD in humans disrupts the pRb -MyoD signaling cascade, * To whom correspondence should be addressed. Tel: +49 60327051101; Fax: +49 60327051104; Email: thomas.braun@mpi-bn.mpg.de (T.B.); matthew.wheeler@mpi-bn.mpg.de (M.W.) which induces myogenic gene expression and cell cycle arrest (11, 12) . The absence of emerin and A-type lamins also leads to abnormal activation of ERK signaling in cardiac muscle (13) . We have shown that emerin forms a complex with b-catenin at the intercalated disc (ID) of cardiomyocytes (14) . Loss of emerin leads to release of b-catenin from the ID, thereby implicating a role of the emerin-b-catenin complex in the intercalated disc and for regulation of b-catenin signaling in cardiomyocytes.
b-catenin is an essential component of adherens junctions mediating cell -cell contacts and also acts as a transcriptional coactivator of the T-cell factor/lymphoid enhancer factor (TCF/LEF) complex. Loss of b-catenin during early heart formation results in multiple heart defects and lethality demonstrating its crucial function for embryonic heart development (15) . The absence of Wnt/b-catenin signaling seems to be required for generation of the first heart field while formation of the second heart field may depend on the correct amount and timing of Wnt/ b-catenin signaling (16) . In adults, b-catenin signaling plays an important role in normal and stress-induced cardiac hypertrophic remodeling (17) . Several studies demonstrated that Wnt/b-catenin signaling acts in a stage-specific biphasic manner, either promoting or inhibiting cardiogenesis. Available evidence suggests that Wnt/b-catenin signaling is required to maintain and expand cardiac precursor lineages but needs to be repressed to promote differentiation of cardiomyocytes (reviewed in 18).
Critically missing from previous studies is the analysis of effects of emerin on the Wnt/b-catenin pathway, which might be of crucial importance for development of cardiac defects in X-EDMD. Here, we examined the function of emerin in the embryonic and postnatal heart. We show that loss of emerin during early developmental stages restricts cardiomyocyte differentiation and promotes proliferation thereby allowing increased formation of additional cardiomyocytes while emerin-null adult mice suffer from cardiac dysfunction and aberrant hypertrophic remodeling following stress. We conclude that the NE protein emerin is an essential component of the cellular apparatus constraining and fine-tuning Wnt/b-catenin signaling.
RESULTS

Constitutive inactivation of emerin in mice increases the number of cardiomyocytes in adult hearts
Previous analysis of adult Emd 2/y mice did not uncover a major pathology in skeletal and heart muscle although skeletal muscle regeneration was delayed associated with perturbations in transcriptional pathways regulated by the retinoblastoma (Rb1) and MyoD genes (12, 14) . We reasoned that a more detailed analysis of adult Emd 2/y hearts might reveal defects that escaped the initial analysis. Interestingly, we detected a clear increase in the number of cardiomyocytes in 5-week-old Emd 2/y hearts using confocal microscopy on dystrophin and DAPI (4 ′ ,6-diamidino-2-phenylindole) stained 6 mm heart sections ( Fig. 1A and B) . To further validate these data we compared the number of cardiomyocytes isolated from 5-week-old WT and Emd 2/y hearts under identical conditions. Again, we monitored a significant increase of the total number of cardiomyocytes in mutant hearts compared with controls (Fig. 1C) . Since size and left ventricular mass of WT and Emd 2/y hearts did not differ significantly (see below) we reasoned that loss of emerin leads to a reduction of the size of cardiomyocytes probably to compensate for increased numbers. In fact, morphometric measurements of freshly isolated cardiomyocytes from Emd 2/y and wild-type littermates revealed a significant reduction of the mean cardiomyocyte area, which was also confirmed on sections co-stained with b-catenin and laminin ( Fig. 1D and E) . The reduced mean cardiomyocyte area corresponded to increased numbers of small and reduced numbers of large cardiomyocytes in mutants compared with WT (Fig. 1F) . Furthermore, we detected a significant increase of mononucleated and a decrease of multinucleated cardiomyocytes in mutants compared with wild-type hearts while the number of bi-nucleated cardiomyocytes remained unchanged (Fig. 1G) . Taken together our results suggest that loss of emerin increases the number of relatively small, mononucleated cardiomyocytes in the adult heart.
Suppression of emerin expression in mouse ES cells causes hyperproliferation and delays cardiac differentiation
Since emerin-null hearts contained increased numbers of small cardiomyocytes, we speculated that emerin might control the extent of cardiomyocyte progenitor proliferation and/or differentiation thereby determining the size of the cardiomyocyte population. To address this question we first turned to an in vitro system allowing generation of differentiated beating cardiomyocytes from mouse embryonic stem (ES) cells via formation of embryoid bodies (EBs) and cardiac bodies (CBs) (19) . Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) analysis revealed a robust increase of emerin expression during differentiation of ES cells into cardiomyocytes indicating a potential function of emerin during formation of cardiomyocytes ( Fig. 2A) . Next, we generated stable ES cell lines, in which expression of emerin was knocked-down by Figure S2 ). Recent studies have identified Flk-1 (KDR, VEGFR2) as a marker of cardiovascular progenitor cells (20) . These Flk-1 +ve progenitors are negatively regulated by Wnt/ b-catenin signaling and are characterized by high Nkx2.5 expression, expression of smooth muscle actin (SMA) and low levels of CD31 (21, 22) . Interestingly, we observed significantly higher expression of Flk-1, Nkx2.5 and SMA concomitant with reduced CD31 levels in Day 6 shEmd EBs suggesting an expansion of cardiac precursor cells (Fig. 2G, I , J and K). Taken together our data suggest that emerin, at least in an in vitro system of cardiomyocyte differentiation, promotes differentiation of ES cells into the cardiac lineage.
Enhanced Wnt/b-catenin activity in emerin-depleted cells impairs cardiac differentiation
Since Wnt/b-catenin signaling acts in a stage-specific biphasic manner, either promoting or inhibiting cardiogenesis and emerin is able to form complexes with b-catenin we wondered Fig. S3 ).
Since our results indicated that emerin restrains Wnt/bcatenin signaling primarily when the pathway is activated we specifically analyzed the impact of emerin on b-catenin activity during early cardiac differentiation when Wnts are expressed at highest levels (Supplementary Material, Fig. S1 ) (23, 24) . Wnt/ b-catenin was analyzed in emerin knock-down and control ES cells induced to differentiate into CBs. We detected a strong up-regulation of TOPFLASH activity indicative of b-catenin signaling in control ES cells 3 days after EB formation compared with Day 1 consistent with previous reports (24, 25) . Repression of emerin expression significantly increased b-catenin activity demonstrating that emerin suppresses Wnt-dependent b-catenin during differentiation of ES cells into cardiomyocytes (Fig. 3B ). Expression analysis of Wnt/b-catenin target genes Axin2 and brachyury confirmed that emerin restrains b-catenin activity in differentiating ES cells (Fig. 3C) . To further analyze whether increased proliferation and delayed differentiation of emerin-depleted cells was caused by reduced suppression of Wnt/b-catenin signaling we applied the b-catenin inhibitor, FH535 (26) to Day 4 EB cultures. Inhibition of b-catenin activity was confirmed by reduced expression of Axin2 4 days after formation of EBs (Supplementary Material, Figure S4 ). The b-catenin inhibitor FH535 did not alter the number of proliferating cells as measured by EdU incorporation in shCon ES cells 5 days after induction of differentiation nor did it repress formation of cardiomyocytes at Day 9 as monitored by aMHC and bMHC expression ( Fig. 3D and E) . Remarkably, however, inhibition of Wnt/b-catenin activity by FH535 restored the proliferation rate in shEmd EBs to that of control cells while enhancing the expression levels of aMHC and bMHC ( Fig. 3D and E). Furthermore, pharmacological inhibition of Wnt/ b-catenin signaling rescued formation of beating shEmd CBs (Fig. 3F) . Overexpression of b-catenin in EBs recapitulated the proliferation and cardiac differentiation defects observed in emerin-null EBs (Supplementary Material, Figure S5 ). We concluded that emerin restrains excessive Wnt/b-catenin signaling, which promotes cell proliferation and interferes with cardiomyocyte differentiation in an in vitro model of cardiogenesis.
Emerin restricts Wnt/b-catenin signaling in developing embryonic mouse hearts
To investigate whether emerin also controls Wnt/b-catenin activity in developing mouse hearts in vivo we crossed emerinmutant mice with the BATGAL reporter mouse strain (27) (Fig. 4A and B ). In contrast, Wnt/b-catenin activity was up-regulated in hearts of emerin KO embryos. The strongest expression was seen in parts of the myocardium and in the atrioventricular canal ( Fig. 4A and B) . Since activation of b-catenin favors proliferation over differentiation (29) we investigated whether increased Wnt/b-catenin activity in emerin-null hearts was associated with increased proliferation. Staining for phospho-histone H3 (PH3) revealed a significant increase in the number of PH3 +ve cells in E12.5 hearts lacking emerin compared with wild-type littermates ( Fig. 4C and D) . However, no differences in proliferation rate were detected in E16.5 and P2 hearts suggesting that the effect of emerin in restricting cardiomyocyte proliferation is strongest at early stages of heart development ( Fig. 4C and D, Supplementary Material, Fig. S6 ).
Lack of emerin compromises cardiac function and impairs response to pressure overload
The increased Wnt/b-catenin activity and the changes in myocardial architecture of emerin-null hearts prompted us to investigate more closely cardiac functions in adult animals. Analysis of heart weight:tibia length revealed a slight but significant increase of Emd 2/y hearts compared with wild-type littermates (Supplementary Material, Fig. S7 ). However we did not observe any gross cardiac pathology consistent with previous studies (12, 29) . Functional magnetic resonance imaging (MRI) of Emd 2/y mice and wild-type controls revealed a significantly lower ejection fraction (EF) of both the right and left ventricle in Emd 2/y mice (Fig. 5A ). Likewise, we detected significantly increased end-diastolic (EDV) and end-systolic volumes (ESV) in Emd 2/y mice (Fig. 5A ) associated with increased levels of the cardiac stress markers ANP and BNP (Fig. 5B) . In contrast, we did not find any signs of increased fibrosis in Emd 2/y hearts (data not shown). We next investigated the ability of Emd 2/y hearts to cope with pathological conditions induced by transverse aortic constriction (TAC)-induced pressure-overload over a period of 6 months. Mice were analyzed by MRI prior to TAC and subsequently at 3 weeks, 3 months and 6 months post-TAC. TAC-operated WT mice showed a typical increase of left ventricular mass (LVM) compared with sham-operated mice during the observation period of 6 months (Supplementary Material, Fig. S8 ) but did not show a significant decline of the EF or an increase of the ESV due to the moderate constriction applied. In stark contrast, we observed a major decline of the EF and increase of ESV of Emd 2/y hearts 3-and 6-months after TAC (Fig. 5C) . Interestingly, the loss of emerin had no discernable effect on the increase of LVM after TAC compared with WT littermates indicating that emerin is required to maintain cardiac function under pressure overload independent of the efficiency of hypertrophic growth (Fig. 5C) . Analysis of expression of ANP, BNP and bMHC mRNA, which are reactivated under stress conditions, in 6-month sham-and TAC-operated WT and Emd 2/y hearts uncovered exacerbated expression in the LV of Emd 2/y hearts while expression increased only marginally in the RV (Fig. 5D) . No change was found in the expression of GATA4 or aMHC (data not shown). Along with increased expression of ANP, BNP and bMHC mRNA we also observed an up-regulation of a-SM-actin expression in cardiomyocytes of Emd 2/y hearts (Fig. 5E ) reflecting increased cardiac remodeling (30) . In summary, our results demonstrate that emerin is required in the heart under baseline conditions to maintain regular cardiac function and is necessary to cope with the consequences of pressure-induced cardiac overload.
Inactivation of a single allele of b-catenin rescues cardiac dysfunction in emerin-null mice
Since b-catenin activity is required for physiological and stress-induced cardiac hypertrophy (17, 31) and Wnt/b-catenin +ve cells in wild-type and emerin-null hearts. At least 10 sections from three hearts for each group were analyzed. P , 0.001. signaling is increased in emerin-deficient embryonic hearts we studied a potential up-regulation of b-catenin activity in the adult myocardium of Emd 2/y mice under baseline conditions and after TAC. We detected a significant increase of the b-catenin target genes Axin2 and BMP4 in young and old Emd 2/y hearts compared with wild-type mice indicating that loss of emerin triggers a gradual increase of b-catenin activity (Fig. 6A) . We also found increased b-catenin expression in young and old Emd 2/y hearts at the RNA level indicating that lack of emerin promotes transcriptional activity of the b-catenin gene, which is in line with previous observations (32) . The increased propensity of emerin-mutant hearts for b-catenin signaling was also reflected by higher expression of b-catenin target genes and of b-catenin 3 weeks after TAC in Emd 2/y compared with WT hearts, which was not apparent anymore 6 months after TAC (Fig. 6B-E) . We conclude that loss of proper repression of b-catenin signaling due to the absence of emerin leads to exacerbated responses of the mutant myocardium compromising cardiac functions after pressure overload. WT mice reach the same level of b-catenin signaling only relatively late, which seems a prerequisite for maintaining EF and ESV during hypertrophic remodeling.
To investigate the functional impact of increased b-catenin signaling for the impaired ability of Emd 2/y mice to respond to pressure overload we generated Emd 2/y /b-cat +/2 mice, which results in a decrease of b-catenin expression (Fig. 6F) . Importantly, reduction of b-catenin expression in emerin-mutant mice rescued the decreased EF and increased ESV of emerinnull hearts (Fig. 6G and H) , although the expression of ANP and BNP remained high (Fig. 6I) . Moreover, we found that both the increased number and reduced cell size of Emd 2/y cardiomyocytes was normalized in Emd 2/y /b-cat +/2 mice ( Fig. 6J  and K) . Taken together our results strongly suggest emerinmediated restriction of Wnt/b-catenin signaling plays an important role to adjust the level of b-catenin signaling. Failure of this mechanism due to the absence of emerin leads to increased numbers of cardiomyocytes, smaller cardiomyocyte size, cardiac dysfunction and impaired ability to cope with the consequences of pressure-induced hypertrophic remodeling.
DISCUSSION
An important clinical feature of X-EDMD is the relatively late onset of congestive heart failure due to dilated cardiomyopathy and conduction defects. Emerin-null mice, which were generated in two different laboratories seemed to reflect the human phenotype only partially but showed defects in muscle regeneration and minimal motor and cardiac dysfunctions (12, 29) . However, studies of emerin-mutant hearts in mice relied so far mostly on analysis of electrocardiograms and preliminary histological investigations. In the current study, we used functional MRI, which provides accurate measurements of cardiac functions, and careful morphometric analysis of myocardial tissue both under physiological and induced pathological conditions. We found that emerin restricts Wnt/b-catenin signaling and loss of emerin results in increased numbers of cardiomyocytes that are smaller than their WT counterparts. Emerin-null mice exhibited cardiac dysfunction under physiological conditions and were unable to maintain EF and ESV during hypertrophic remodeling after long-term pressure overload. The cardiac phenotype of emerin-null mice that we detected in our study indicates a general role of LEM proteins in the regulation of heart morphogenesis and function, since inactivation of MAN1 and LAP2a also causes cardiac abnormalities (33 -35) . Homozygous gene-trapped MAN1 mice display abnormal heart morphogenesis associated with defects in left/right axis formation while mice lacking Lap2a exhibit cardiac dysfunction and are more susceptible to cardiac fibrosis.
Our findings suggest a physiologically important role for emerin as a modifier of Wnt/b-catenin signaling in the heart and explain the increase of components of the Wnt pathway in emerin-null mice (13) . Previous studies revealed that it is essential to suppress Wnt/b-catenin activity during embryonic heart development to allow terminal differentiation of cardiomyocytes (36, 37) . The situation in the adult remodeling heart seems to be similar: Wnt/ b-catenin signaling is essential for cardiac remodeling following stress but needs to be fine-tuned to avoid maladaptive responses leading to heart failure (17, 31, 38, 39) . Correspondingly, we observed increased b-catenin signaling in the absence of emerin both during embryonic development and in the stressed adult heart resulting in increased cardiomyocyte proliferation and impaired cardiac function.
Emerin is known to repress gene activity by binding and recruiting HDAC3 to the NE periphery (40) and by limiting up-regulation of CBP and p300, thereby restricting b-catenin binding to its target promoters (41) . Emerin together with other NE proteins recruit/sequester specific regions of the genome at the inner nuclear membrane, which goes along with acquisition of repressive chromatin marks and transcriptional silencing (9, 42, 43) . At the same time, the shift of genomic regions away from the inner nuclear membrane will allow recruitment of factors including histone acetylases (HATs), histone remodeling complexes, histone-shuffling ATPases, SET-domain histone methyltransferases (HMTs), BCL-9 and pygopus, which have all been shown to be involved in the activation of Wnt target genes following interaction of b-catenin with TCF. Hence, loss of emerin will facilitate transcriptional activation and impair inactivation of target genes. Wnt/b-catenin target genes and the b-catenin gene itself seem particularly susceptible to impaired inactivation probably because Wnt/ b-catenin target genes are actively repressed by a complex consisting of TCFs, groucho and histone deacetylases (HDACs) in the absence of an activating signal (44) .
To this end, it has become increasingly clear that NE proteins, in part by controlling activity of the Wnt/b-catenin pathway, are important regulators of the cell cycle since the loss of LAP2a, A-type lamins, lamin B receptor and LEM2 leads to proliferation defects (45 -49) . The disrupted balance between cellular proliferation and differentiation after loss of NE proteins is also reflected by the deregulation of numerous signaling pathways (11,12,14,50 -52) and by abnormalities in cell cycle parameters of muscle stem cells resulting in delayed myogenic differentiation during skeletal muscle regeneration of emerin-mutant mice (12) . Our results are in line with these findings and establish a novel role for emerin in restraining cardiomyocyte proliferation by repressing Wnt/b-catenin signaling. Future experimental approaches based on chromosome conformation capture techniques and ChIP-seq will provide key insights how the loss of emerin alters high-order chromatin organization and affects the interaction between b-catenin and target genes during cardiomyocyte differentiation/hypertrophy (53) .
Our study uncovered a key role for emerin in buffering the activity of b-catenin during embryonic heart development and during postnatal cardiac remodeling (Fig. 6K) . We propose that disruption to the emerin-b-catenin signaling axis contributes to cardiac defects observed in X-EDMD. Intriguingly, recent studies using Lmna H222P/H222P mice as a model of autosomal EDMD, demonstrated that systemic treatment with ERK and JNK inhibitors significantly improved cardiac function (54, 55) . Careful adjustment of Wnt/b-catenin signaling activity in EDMD hearts using available inhibitors might help to achieve an improved clinical outcome.
MATERIALS AND METHODS
Animal models
Emerin KO and b-catenin KO mice were generated on a C57BL/ 6 genetic background and have been described previously (12, 14, 56) . For transverse aortic constriction (TAC) experiments, wild-type or Emd 2/y mice were anesthetized with inhaled 1.5-2.0% Isoflurane, intubated and ventilated with oxygen. To induce mild pressure overload of the left ventricle, a constriction of the transverse aorta (TA) was generated by exposing the outflow tract (OT) after right-sided upper thoracotomy and applying a surgical suture with the support of a 26 gauge needle. In all experiments littermate controls were used if not indicated otherwise. Following the separation of the left and right ventricles, heart samples were snap-frozen for further analysis.
All animal experiments in this study were performed with the approval of the local animal care committee.
MRI measurements
Cardiac MRI was performed on a Bruker Pharmascan 7.0T, equipped with a 300 mT/m gradient system, using a custom-built circularly polarized birdcage resonator and the Early Access Package for self-gated cardiac imaging (Intragate, Bruker, Ettlingen, Germany). All MRI data were analyzed using Qmass digital imaging software (Medis, Leiden, the Netherlands).
Antibodies
Antibodies to emerin were described previously (14) . The MF20 antibody was obtained from the Developmental Studies Hybridoma Bank, b-catenin (9562) and phospho-histone H3 Ser-10 (9701) were from Cell Signaling while actin (A 2668), alpha-smooth muscle actin (A 2547) and dystrophin (D8168) were purchased from Sigma.
Cell culture
Mouse embryonic stem (ES) cells carrying a neomycin resistance gene under the control of the aMHC promoter were cultured according to (19) . ES cells were maintained on mouse embryonic fibroblasts (MEFs) and kept in an undifferentiated state by the addition of leukemia inhibitory factor (LIF, 1000 units/ml) to ES culture medium [Dulbecco's modified Eagle's medium (DMEM), 15% FCS, 1× non-essential amino acids, 1 mM 2-Mercaptoethanol]. To initiate differentiation, ES cells were trypsinized and resuspended in ES cell differentiation medium (ES culture medium without LIF) at 1 × 10 6 cells/ 100 mM bacterial petri dish. Differentiating EBs were formed in rotating dishes. For inhibition of Wnt/b-catenin activity FH535 (Calbiochem) was added to a final concentration of 15 mM. Cardiomyocytes were selected by supplementing the media with G418 (400 mg/ml; Invitrogen) to eliminate cells not expressing the neomycin resistance gene. For EdU incorporation, EBs were incubated overnight in medium containing 10 mM EdU (Invitrogen). Incorporated EdU was detected with a fluorescence-coupled azide according to manufacturer's instructions. After staining, EB's were incubated overnight in 30% sucrose in phosphate buffered saline (PBS) and mounted in tissue-tek for sectioning.
Transfections and generation of stable shRNA cell lines MISSION shRNA clones in a pLKO.1 vector backbone were obtained from Sigma. A non-targeting control shRNA (SHC002) and emerin shRNA (NM_007927.2-934s21c1) vectors were transfected into ES cells using lipofectamine (Invitrogen) according to manufacturer's instructions. Stable clones were selected with puromycin (1.5 mg/ml final). Stocks were prepared. Only cultures at less than P20 were used for experiments.
Immunohistochemistry
Cells or EBs were fixed with 4% PFA for 15 min, permeabilized with 0.2% Triton X-100 in PBS and blocked with 5% horse serum in PBS. Primary antibodies were diluted in 1% BSA in PBS and incubated with cells overnight at 48C. Cells were washed three times with PBS and incubated with fluorophoreconjugated secondary antibodies diluted in 1% BSA in PBS. Nuclei were stained with DAPI for 15 min before mounting with vectorshield to prevent fading. Images were captured on a Zeiss Axiovert 200 M inverted microscope. Confocal images were obtained using a Leica LSM SP2 AOBS microscope.
Lac Z staining of embryonic hearts
Whole embryos were fixed for 40 min in 1× PBS containing 1% formaldehyde, 0.2% glutaraldehyde and 0.02% NP40. After washing twice with PBS for 20 min, embryos were stained overnight in 1× PBS with 40 mg/ml X-Gal, 500 mM K 3 Fe(CN) 6 , 500 mM K 4 Fe(CN) 6 and 100 mM MgCl 2 . The embryos were washed with PBS and incubated in 30% sucrose before embedding in tissue-tek and sectioning.
Western blotting
Western blotting was described previously (14) . Briefly, cells or tissue was resuspended in SDS-PAGE sample buffer. Protein extract was separated by SDS-PAGE, transferred to nitrocellulose and blocked in 5% non-fat milk in TBS with 0.1% Tween20 (Blocking buffer). Membranes were immunoblotted with indicated antibodies diluted in blocking buffer overnight at 48C. Membranes were washed and further incubated with appropriate secondary antibodies conjugated to horseradish peroxidase (HRP) (PerkinElmer) and signal intensities were visualized by Chemiluminescence (ChemiDoc TM imaging system, Biorad).
Luciferase reporter activity assay ES cells were plated at 50 × 10 4 cells/well in 48-well plates 24 h prior to transfection. Cells were transfected with 50 ng of pRL-TK (Renilla luciferase) together with 500 ng TOPFLASH (firefly luciferase reporter under control of TCF/LEF-responsive elements) or the control plasmid, FOPFLASH using lipofectamine. After 24 h, cells were incubated overnight in DMEM containing low serum (0.2% FCS) and subsequently treated with LiCl (20 mM) as indicated. Cells were lysed in 1× lysis buffer and assayed for firefly luciferase (TopFlash) and Renilla (pRL-TK) luciferase activity using a dual luciferase assay kit (Promega). Reporter activity was calculated as the ratio of activities of firefly luciferase to Renilla.
qRT-PCR
RNA was extracted using TRIZOL (Invitrogen) according to manufacturer's instructions and reverse-transcribed (1 mg RNA) into cDNA using with Superscript II reverse transcriptase (Invitrogen). cDNA (500 ng) was used for SYBR Green based real-time PCR using the RT2 SYBR Green Mastermix (SABiosciences, Qiagen). The following primer pairs were used:
aMHC Fwd: TGGTCACCAACAACCCATACGACT, Rev: TGTCAGCTTGTAGACACCAGCCTT bMHC Fwd: GCCAACACCAACCTGTCCAAGTTC, Rev: TGCAAAGGCTCCAGGTCTGAGGGC
